Investigative Site — Everett, Washington

Investigative Site is a clinical research site located in Everett, Washington, United States 98208.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site has participated in 2 clinical trials.

Therapeutic areas: Overactive Bladder (OAB), Irritable Bowel Syndrome With Diarrhea (IBS-D).

Sponsors: Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Everett

Browse all research sites in Washington · View every site in Everett

• Providence Hospital - Pacific Campus; Flynn Cancer Center
• Washington State University at Everett
• Providence Hospital
• Providence Regional Cancer Partnership
• Core Clinical Research
• Providence Regional Medical Center Everett
• Providence Regional Medical Center
• Western Washington Medical Group
• GSK Investigational Site
• Research Site
• Eastside Therapeutic Resource dba Core Clinical Research
• Providence Everett Medical Center

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site?

Investigative Site has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site conducted?

Investigative Site has 2 clinical trials on record. Their work covers Overactive Bladder (OAB), Irritable Bowel Syndrome With Diarrhea (IBS-D).

Is Investigative Site accredited by Crixeo Clinical Trials?

Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.